Niedan, S <br/><br/>
Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.  [electronic resource] 

 -  Oncogene  Jul 2014 
 - 3927-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2013.361  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Base Sequence<br/>Binding Sites<br/>Bone Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Consensus Sequence<br/>Cyclin-Dependent Kinase 2--metabolism<br/>Forkhead Box Protein O1<br/>Forkhead Box Protein O3<br/>Forkhead Transcription Factors--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Humans<br/>Mice<br/>Oncogene Proteins, Fusion--genetics<br/>Organoselenium Compounds--pharmacology<br/>Phosphorylation<br/>Promoter Regions, Genetic<br/>Protein Processing, Post-Translational<br/>Protein Transport<br/>Proto-Oncogene Protein c-fli-1--genetics<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>RNA-Binding Protein EWS--genetics<br/>Sarcoma, Ewing--drug therapy<br/>Transcription, Genetic<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays